Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD3 is a multimeric protein complex associated with the T cell receptor (TCR) on T lymphocytes. It is essential for TCR assembly, surface expression, and signal transduction following antigen recognition. The complex consists of CD3εγ, CD3εδ, and CD3ζζ dimers. Upon antigen binding to the TCR, ITAM motifs within the CD3 cytoplasmic tails are phosphorylated, initiating downstream signaling cascades that lead to T cell activation. CD3 is expressed on all mature T cells and is used as a marker for identifying and quantifying T cells. Anti-CD3 antibodies are used therapeutically to modulate immune responses, such as in transplant rejection.
CD3 modulation, T cell depletion/tolerization
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell Surface Antigen CD3 (CD3).